Inhibitor of complement, Compstatin, prevents polymer-mediated Mac-1 up-regulation of human neutrophils independent of biomaterial type tested

Journal of Biomedical Materials Research - Part A

Volumn 66, Issue 3, 2003, Pages 491-499

  Schmidt, S ^a   Haase, G ^a   Csomor, E ^a   Lutticken R ^a   Peltroche Llacsahuanga, H ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Biomaterial; Complement; Compstatin; Mac 1 adhesion receptor; Neutrophil

Indexed keywords

BIOASSAY; BLOOD; POLYMERS; POLYMETHYL METHACRYLATES; PROTEINS; SURFACE CHEMISTRY;

CELL FUCTIONS;

BIOMATERIALS;

BIOMATERIAL; CD11B ANTIGEN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT INHIBITOR; COMPSTATIN; FIBRINOGEN; IMMUNOGLOBULIN G; POLY(METHYL METHACRYLATE); POLYLACTIDE; POLYMER; POLYURETHAN; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL CONTACT; COMPLEMENT INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL;

EID: 0344306456     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.10031     Document Type: Article

References (41)

1. Ward RA. Phagocytic cell function as an index of biocompatibility. Nephrol Dial Transplant 1994;9:46-56.
2. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. Neutrophils: Molecules, functions, and pathophysiological aspects. Lab Invest 2000;80:617-653.
3. Gorbet MB, Yeo EL, Sefton MV. Flow cytometric study of in vitro neutrophil activation by biomaterials. J Biomed Mater Res 1999;44:289-297.
4. Peltroche-Llacsahuanga H, Schmidt S, Schnitzler N, Lütticken R, Haase G. Simultaneous measurement of biopolymer-mediated Mac-1 up-regulation and adherence of neutrophils: A novel flow cytometric approach for predicting initial inflammatory interaction with foreign materials. J Immunol Methods 2001;258:13-25.
5. Tang L, Eaton JW. Mechanism of acute inflammatory response to biomaterials. Cell Mater 1994;4:429-436.
6. Hlady V, Andrade JD, Ho CH, Tingey K. Plasma protein adsorption on model biomaterial surfaces. Clin Mater 1993;13:85-93.
7. Anderson JM, Bonfield TL, Ziats NP. Protein adsorption and cellular adhesion and activation on biomedical polymers. Int J Artif Organs 1990;13:375-382.
8. Hu WJ, Eaton JW, Tang L. Molecular basis of biomaterial-mediated foreign body reactions. Blood 2001;98:1231-1238.
9. Jenney CR, Anderson JM. Adsorbed serum proteins responsible for surface dependent human macrophage behavior. J Biomed Mater Res 2000;49:435-447.
10. Jenney CR, Anderson JM. Adsorbed IgG: A potent adhesive substrate for human macrophages. J Biomed Mater Res 2000;50:281-290.
11. Wetterö J, Bengtsson T, Tengvall P. Complement activation on immunoglobulin G-coated hydrophobic surfaces enhances the release of oxygen radicals from neutrophils through an actin-dependent mechanism. J Biomed Mater Res 2000;51:742-751.
12. Craddock PR, Fehr J, Dalmasso AP, Brighan KL, Jacobs HS. Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977;59:879-888.
13. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes: An in vitro model of immune vascular damage. J Clin Invest 1978;61:1161-1167.
14. Haeffner-Cavaillon N, Cavaillon JM, Laude M, Kazatchkine MD. C3a (C3ades Arg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol 1987;139:794-799.
15. Janatova J. Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers. ASAIO J 2000;46:53-62.
16. Sahu A, Kay BK, Lambris JD. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J Immunol 1996;157:884-891.
17. Fiane AE, Mollnes TE, Videm V, Hovig T, Hogasen K, Mellbye OJ, Spruce L, Moore WT, Sahu A, Lambris JD. Compstatin, a peptide inhibitor of C3, prolongs survival of ex vivo perfused pig xenografts. Xenotransplantation 1999;6:52-65.
18. Soulika AM, Khan MM, Hattori T, Bowen FW, Richardson BA, Hack CE, Sahu A, Edmunds LH Jr, Lambris JD. Inhibition of heparin/protamine complex-induced complement activation by Compstatin in baboons. Clin Immunol 2000;96:212-221.
19. Furlong ST, Dutta AS, Coath MM, Gormley JJ, Hubbs SJ, Lloyd D, Mauger RC, Strimpler AM, Sylvester MA, Scott CW, Edwards PD. C3 activation is inhibited by analogs of Compstatin but not by serine protease inhibitors or peptidyl alpha-keto-heterocycles. Immunopharmacology 2000;48:199-212.
20. van Eeden SF, Klut ME, Walker BA, Hogg JC. The use of flow cytometry to measure neutrophil function. J Immunol Methods 1999;232:23-43.
21. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection: Evidence for a local granulocyte defect. J Clin Invest 1984;73:1191-1200.
22. Tang L, Ugarova TP, Plow EF, Eaton JW. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest 1996;97:1329-1334.
23. Kazatchkine MD, Carreno MP. Activation of the complement system at the interface between blood and artificial surfaces. Biomaterials 1988;9:30-35.
24. Janatova J, Cheung AK, Parker CJ. Biomedical polymers differ in their capacity to activate complement. Complement Inflamm 1991;8:61-69.
25. Andersson J, Ekdahl KN, Larsson R, Nilsson UR, Nilsson B. C3 adsorbed to a polymer surface can form an initiating alternative pathway convertase. J Immunol 2002;168:5786-5791.
26. Ino Y, Sato T, Suzuki S, Iwaki M, Yoshikawa T. Inhibitory effects of FUT-175, a new synthetic protease inhibitor, on intravascular hemolysis by human serum in mice. Int J Immunopharmacol 1987;9:533-537.
27. Sundaram S, Lim F, Cooper SL, Colman RW. Role of leukocytes in coagulation induced by artificial surfaces: Investigation of expression of Mac-1, granulocyte elastase release and leucocyte adhesion on modified polyurethanes. Biomaterials 1996;17:1041-1047.
28. Kam CM, Oglesby TJ, Pangbum MK, Volanakis JE, Powers JC. Substituted isocoumarins as inhibitors of complement serine proteases. J Immunol 1992;149:163-166.
29. Higgins PJ, Ko JL, Lobell R, Sardonini C, Alessi MK, Yeh CG. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities. J Immunol 1997;158:2872-2881.
30. Rinder CS, Rinder HM, Johnson K, Smith M, Lee DL, Tracey J, Polack G, Higgins P, Yeh CG, Smith BR. Role of C3 cleavage in monocyte activation during extracorporal circulation. Circulation 1999;100:553-558.
31. Lundgren B, Ocklind A, Holst A, Harfstrand A. Inflammatory response in the rabbit eye after intraocular implantation with poly(methyl methacrylate) and heparin surface modified intraocular lenses. J Cataract Refract Surg 1992;18:65-70.
32. Rinder CS, Rinder HM, Smith BR, Fitch JC, Smith MJ, Tracey JB, Matis LA, Squinto SP, Rollins SA. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest 1995;96:1564-1572.
33. Nilsson B, Larsson R, Hong J, Elgue G, Ekdahl KN, Sahu A, Lambris JD. Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 1998;92:1661-1667.
34. Himmelfarb J, McMonagle E, Holbrook D, Toth C. Soluble complement receptor 1 inhibits both complement and granulocyte activation during ex vivo hemodialysis. J Lab Clin Med 1995;126:392-400.
35. Lazar HL, Bao Y, Gaudiani J, Rivers S, Marsh H. Total complement inhibition: An effective strategy to limit ischemic injury during coronary revascularization on cardiopulmonary bypass. Circulation 1999;100:1438-1442.
36. Yung LY, Cooper SL. Neutrophil adhesion on phosphorylcholine-containing polyurethanes. Biomaterials 1998;19:31-40.
37. Trindade MC, Lind M, Goodman SB, Maloney WJ, Schurman DJ, Smith RL. Interferon-gamma exacerbates polymethyl-methacrylate particle-induced interleukin-6 release by human monocyte/macrophages in vitro. J Biomed Mater Res 1999;47:1-7.
38. Sirolli V, Di Stante S, Stuard S, Di Liberato L, Amoroso L, Cappelli P, Bonomini M. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis. Int J Artif Organs 2000;23:356-364.
39. Chang CC, Rosenson-Schloss RS, Bhoj TD, Moghe PV. Leukocyte chemosensory migration on vascular prosthetic biomaterial is mediated by an integrin beta2 receptor chain. Biomaterials 2000;21:2305-2313.
40. Maxfield A, Lewis J, Lachenmayr S, Tisdale J, Lum M. A National Institute for Occupational Safety and Health Alert sent to hospitals and the intention of hospital decision makers to advocate for latex allergy control measures. Health Educ Res 2000;15:463-467.
41. Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberg A, Flyvbjerg A, Haas NP, Raschke M. Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly-(D,L)-lactide coating of osteosynthetic implants accelerates fracture healing in rats. Bone 2001;28:341-350.